Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (231-240 of 432) with videos related to

Pageof 44
Sort By:
Transplantation|February 1, 1988
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allograftsK P Batts, S B Moore, J D Perkins, et al.
Journal of Hepatology|December 1, 1994
Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipientsD I Ninova, R H Wiesner, G J Gores, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantationAlberto Rubio-Tapia, Ahmad S Abdulkarim, Russell H Wiesner, et al.
Mayo Clinic Proceedings|January 1, 1989
Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantationS R DiCecco, E J Wieners, R H Wiesner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitisJohn R Lake, Jolene S Shorr, Bettina J Steffen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis CRussell H Wiesner, Jolene S Shorr, Bettina J Steffen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM)D A Axelrod, M K Guidinger, R A Metzger, et al.
Mayo Clinic Proceedings|August 1, 1996
Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomyA H Kartheuser, R R Dozois, N F LaRusso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantationJ R Lake, K M David, B J Steffen, et al.
Journal of Clinical Microbiology|June 1, 1994
Detection of cytomegalovirus DNA in sera of liver transplant recipientsR Patel, T F Smith, M Espy, et al.
Pageof 44

Showing results (231-240 of 432) with videos related to

Sort By:
Pageof 44
Transplantation|February 1, 1988
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allograftsK P Batts, S B Moore, J D Perkins, et al.
Journal of Hepatology|December 1, 1994
Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipientsD I Ninova, R H Wiesner, G J Gores, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantationAlberto Rubio-Tapia, Ahmad S Abdulkarim, Russell H Wiesner, et al.
Mayo Clinic Proceedings|January 1, 1989
Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantationS R DiCecco, E J Wieners, R H Wiesner, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitisJohn R Lake, Jolene S Shorr, Bettina J Steffen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis CRussell H Wiesner, Jolene S Shorr, Bettina J Steffen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 24, 2006
Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM)D A Axelrod, M K Guidinger, R A Metzger, et al.
Mayo Clinic Proceedings|August 1, 1996
Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomyA H Kartheuser, R R Dozois, N F LaRusso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantationJ R Lake, K M David, B J Steffen, et al.
Journal of Clinical Microbiology|June 1, 1994
Detection of cytomegalovirus DNA in sera of liver transplant recipientsR Patel, T F Smith, M Espy, et al.
Pageof 44